Medical Developments International Ltd (MVP) - Total Liabilities
Based on the latest financial reports, Medical Developments International Ltd (MVP) has total liabilities worth AU$11.29 Million AUD (≈ $7.99 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Medical Developments International Ltd cash flow conversion to assess how effectively this company generates cash.
Medical Developments International Ltd - Total Liabilities Trend (2003–2025)
This chart illustrates how Medical Developments International Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Medical Developments International Ltd (MVP) asset resilience to evaluate the company's liquid asset resilience ratio.
Medical Developments International Ltd Competitors by Total Liabilities
The table below lists competitors of Medical Developments International Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Heimstaden AB Pfd.
ST:HEIM-PREF
|
Sweden | Skr236.74 Billion |
|
Aemulus Holdings Bhd
KLSE:0181
|
Malaysia | RM111.97 Million |
|
Urbanise.com Ltd
AU:UBN
|
Australia | AU$12.05 Million |
|
United Recommend International Co Ltd
TWO:5321
|
Taiwan | NT$4.17 Billion |
|
Hipay Group SA
PA:ALHYP
|
France | €173.68 Million |
|
Inchcape PLC
LSE:INCH
|
UK | GBX4.61 Billion |
|
OTRS AG
F:TR9
|
Germany | €7.20 Million |
|
WHA Business Complex Freehold and Leasehold Real Estate Investment Trust
BK:WHABT
|
Thailand | ฿564.95 Million |
Liability Composition Analysis (2003–2025)
This chart breaks down Medical Developments International Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Medical Developments International Ltd (MVP) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.54 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 2.28 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medical Developments International Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medical Developments International Ltd (2003–2025)
The table below shows the annual total liabilities of Medical Developments International Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$11.29 Million ≈ $7.99 Million |
-15.90% |
| 2024-06-30 | AU$13.43 Million ≈ $9.50 Million |
-52.34% |
| 2023-06-30 | AU$28.17 Million ≈ $19.93 Million |
-36.06% |
| 2022-06-30 | AU$44.06 Million ≈ $31.18 Million |
+38.24% |
| 2021-06-30 | AU$31.87 Million ≈ $22.55 Million |
-38.13% |
| 2020-06-30 | AU$51.51 Million ≈ $36.45 Million |
+28.10% |
| 2019-06-30 | AU$40.21 Million ≈ $28.45 Million |
+41.06% |
| 2018-06-30 | AU$28.51 Million ≈ $20.17 Million |
+41.38% |
| 2017-06-30 | AU$20.16 Million ≈ $14.27 Million |
-9.23% |
| 2016-06-30 | AU$22.21 Million ≈ $15.72 Million |
+298.03% |
| 2015-06-30 | AU$5.58 Million ≈ $3.95 Million |
-17.15% |
| 2014-06-30 | AU$6.74 Million ≈ $4.77 Million |
+48.04% |
| 2013-06-30 | AU$4.55 Million ≈ $3.22 Million |
+53.35% |
| 2012-06-30 | AU$2.97 Million ≈ $2.10 Million |
+31.40% |
| 2011-06-30 | AU$2.26 Million ≈ $1.60 Million |
+50.23% |
| 2010-06-30 | AU$1.50 Million ≈ $1.06 Million |
-4.75% |
| 2009-06-30 | AU$1.58 Million ≈ $1.12 Million |
+13.69% |
| 2008-06-30 | AU$1.39 Million ≈ $982.10K |
+26.87% |
| 2007-06-30 | AU$1.09 Million ≈ $774.07K |
-58.36% |
| 2006-06-30 | AU$2.63 Million ≈ $1.86 Million |
-16.74% |
| 2005-06-30 | AU$3.15 Million ≈ $2.23 Million |
-23.01% |
| 2004-06-30 | AU$4.10 Million ≈ $2.90 Million |
-0.80% |
| 2003-06-30 | AU$4.13 Million ≈ $2.92 Million |
-- |
About Medical Developments International Ltd
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more